IMR Press / EJGO / Volume 40 / Issue 2 / DOI: 10.12892/ejgo4147.2019
Open Access Original Research
Overexpression of CUL4B is a novel predictor of prognosis for endometrial adenocarcinoma
Show Less
1 Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Eur. J. Gynaecol. Oncol. 2019, 40(2), 198–202;
Published: 10 April 2019

Purpose: It is reported that Cullin 4B (CUL4B) plays a crucial role in many physiological process. This study for the first time investigated the role of CUL4B in endometrioid adenocarcinoma (EAC). Materials and Methods: CUL4B mRNA and protein expression in EAC tissues and normal endometrial (NE) tissues were examined by real-time PCR and immunohistochemistry. The authors also explored the correlation between CUL4B protein expression and clinicopathological characteristics. Moreover, univariate and multivariate Cox regression analyses and Kaplan-Meier survival analyses were performed to investigate the association between TRIM62 expression and EAC patients’ prognosis. Results: CUL4B was markedly overexpressed in EAC at both mRNA and protein levels. Immunohistochemistry assays showed that high CUL4B expression was significantly correlated with FIGO stage (p = 0.008) and histological grade (p = 0.002). Univariate and multivariate analyses revealed that CUL4B was an independent poor prognostic factor for overall and disease-free survival of EAC patients (p < 0.05). Furthermore, survival analyses displayed that patients with high CUL4B expression had poor prognosis. Conclusion: The present results demonstrated that elevated CUL4B was associated with poor outcomes of patients with EAC. CUL4B may serve as a novel prognostic marker and therapeutic target for EAC.

Endometrial carcinoma
Figure 1.
Back to top